These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9082062)

  • 1. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of dilated cardiomyopathies. Recent findings].
    Perret C
    Ann Cardiol Angeiol (Paris); 1986 Jun; 35(6):311-6. PubMed ID: 2877610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profiles and outcomes for Omani children with dilated cardiomyopathy seen in a regional referral hospital.
    Jaiyesimi O; Kasem M
    Cardiol Young; 2009 Apr; 19(2):145-51. PubMed ID: 19224668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

  • 6. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
    Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract]   [Full Text] [Related]  

  • 7. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 9. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
    Singh TP; Almond C
    J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
    Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
    Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment guidelines for heart failure stress multidrug approach.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of normalized left ventricular systolic function after discontinuation of treatment in patients with dilated cardiomyopathy.
    Alahakoon PT; Binkley PF
    Congest Heart Fail; 2009; 15(5):245-6. PubMed ID: 19751427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F
    Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutics of congestive myocardial failure: their immediate and remote evaluation].
    Besse P; Coste P; Bernadet P
    Rev Med Interne; 1993; 14(10):928-30. PubMed ID: 7912002
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy.
    Elliott J; Marr CM
    Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should beta-adrenergic blockade be part of drug therapy for heart failure?].
    Leinonen H
    Duodecim; 1995; 111(3):209-13. PubMed ID: 8654281
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of dilated cardiomyopathy].
    Amosova EN
    Ter Arkh; 1994; 66(3):88-91. PubMed ID: 7911259
    [No Abstract]   [Full Text] [Related]  

  • 19. Up to date in pharmacological treatment of dilated cardiomyopathy.
    Ginghina C; Teodorescu A; Stoian I; Serban M; Ghiorghiu I; Wohlfart K
    Rom J Intern Med; 2004; 42(1):3-13. PubMed ID: 15529591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Cayley WE
    Am Fam Physician; 2004 Jan; 69(1):71-2. PubMed ID: 14727819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.